Related Experiment Video
Updated: Jan 19, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
From protein-protein interaction to therapy response: molecular imaging of heat shock proteins
1The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.
Abstract:
HSP70 promoter-driven gene therapy and inhibition of HSP90 activity with small molecule inhibitors are two shining points in a newly developed cohort of cancer treatment. For HSP70 promoters, high efficiency and heat inducibility within a localized region make it very attractive to clinical translation. The HSP90 inhibitors exhibit a broad spectrum of anticancer activities due to the downstream effects of HSP90 inhibition, which interfere with a wide range of signaling processes that are crucial for the malignant properties of cancer cells. In this review article, we summarize exciting applications of newly emerged molecular imaging techniques as they relate to HSP, including protein-protein interactions of HSP90 complexes, therapeutic response of tumors to HSP90 inhibitors, and HSP70 promoters-controlled gene therapy. In the HSPs context, molecular imaging is expected to play a vital role in promoting drug development and advancing individualized medicine.
Insights
Heat shock proteins (HSPs) are key in cancer therapy. Molecular imaging advances understanding of HSP90 inhibitors and HSP70 promoter gene therapy, aiding drug development and personalized medicine.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Heat shock proteins (HSPs) are crucial in cellular stress response and cancer progression.
- HSP70 promoter-driven gene therapy and HSP90 inhibition are promising cancer treatment strategies.
- Molecular imaging offers novel tools to study HSP-related cancer mechanisms.
Purpose of the Study:
- To review the applications of molecular imaging in understanding HSPs in cancer.
- To explore HSP90 inhibitors' anticancer mechanisms and therapeutic responses.
- To discuss HSP70 promoter-controlled gene therapy and its clinical potential.
Main Methods:
- Review of recent literature on molecular imaging techniques applied to HSPs.
- Analysis of studies investigating HSP90 inhibitors and their downstream effects.
- Examination of research on HSP70 promoter-controlled gene therapy.
Main Results:
- HSP70 promoters show high efficiency and heat inducibility for localized gene therapy.
- HSP90 inhibitors demonstrate broad-spectrum anticancer activity by disrupting cancer cell signaling.
- Molecular imaging can visualize HSP90 protein-protein interactions and tumor response to inhibitors.
Conclusions:
- Molecular imaging is vital for advancing HSP-targeted cancer drug development.
- HSP-based therapies, including gene therapy and small molecule inhibitors, hold significant clinical promise.
- Integrating molecular imaging with HSP research facilitates personalized cancer medicine.
More Related Videos
07:23Using High Content Imaging to Quantify Target Engagement in Adherent Cells
Published on: November 29, 2018
14:44A Protocol for the Identification of Protein-protein Interactions Based on 15N Metabolic Labeling, Immunoprecipitation, Quantitative Mass Spectrometry and Affinity Modulation
Published on: September 24, 2012
Related Concept Videos
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Protein Dynamics in Living Cells
Fluorescent recovery after photobleaching (FRAP) is a fluorescent-protein-based detection technique used to quantify protein movement rates within the cell. This method exposes a small portion of the cell to an intense laser beam. The laser beam causes permanent photobleaching of the fluorophore-tagged proteins in the exposed region. As the bleached...
Molecular Chaperones and Protein Folding
The...